Summary & Overview
HCPCS P9056: Whole Blood, Leukocytes Reduced, Irradiated, Each Unit
HCPCS Level II code P9056 designates a single unit of whole blood that has been leukocyte reduced and irradiated. This processed blood product is used to lower risks of immune-mediated transfusion complications, including febrile reactions and transfusion-associated graft-versus-host disease, making it clinically important in immunocompromised patients and certain transfusion protocols. Nationally, accurate coding of processed blood products affects hospital transfusion workflows, inventory management, and payer reimbursements.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what P9056 represents, the primary clinical contexts for use, and where the service is typically delivered. The publication also summarizes common modifiers associated with transfusion services and highlights areas where billing clarity matters for hospitals and blood banks.
This summary provides clinical context and billing relevance for P9056, plus what to expect in the rest of the publication: coding benchmarks, payer coverage considerations, and operational notes for transfusion services. Data not available in the input for payor-specific rates, taxonomies, ICD-10 linkage, and related codes will be presented as unavailable where applicable.
Billing Code Overview
HCPCS Level II code P9056 describes whole blood, leukocytes reduced, irradiated, each unit. This service represents provision of a single unit of whole blood that has undergone leukocyte reduction and irradiation to reduce the risk of febrile nonhemolytic transfusion reactions and transfusion-associated graft-versus-host disease.
-
Service type: Blood product transfusion (processed whole blood unit)
-
Typical site of service: Hospital inpatient and hospital outpatient transfusion settings; blood bank or transfusion service handling prior to administration
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with a history of acute myeloid leukemia is admitted for planned transfusion of whole blood, leukocytes reduced, irradiated because of symptomatic anemia after induction chemotherapy. The transfusion is ordered by the inpatient hematology/oncology team. Pre-transfusion testing (type and screen, crossmatch) and infectious disease screening are completed in the hospital laboratory. The blood bank issues a unit labeled as leukocyte-reduced and irradiated to prevent transfusion-associated graft-versus-host disease and to reduce febrile nonhemolytic transfusion reactions. Nursing performs pre-transfusion vital signs, confirms patient identity with two identifiers, inspects the blood unit, documents the unit number and product modifications (leukocyte reduced, irradiated), and initiates the transfusion per institutional protocol in the inpatient ward. Post-transfusion vital signs and documentation of tolerance or adverse reaction are completed. Billing captures the HCPCS Level II code P9056 for each unit provided, with applicable modifiers appended as required by payer policy and institutional billing rules.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |